Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
07/1992
07/01/1992EP0492020A1 Use of certain esters of hexahydro-8-hydroxy-2,6-methano-2H-quinolizin-3(4H)-one and related compounds for treating cognitive disorders
07/01/1992EP0491792A1 Methods of treating neurodegenerative conditions
07/01/1992EP0491770A1 Substituted urea compounds and their preparation and use
07/01/1992CN1017245B Imidazolidinone compound and processes for preparation thereof
07/01/1992CN1017242B New quianzoline derivatives and process for their production
06/1992
06/30/1992US5126375 Asthma, chronic bronchitis
06/30/1992US5126353 Compositions and method of treating arrythmia with tetrahydropyridines
06/30/1992CA1304381C 3-(piperidin-1-yl)-carbonylmethyl-isoindolin-1-one
06/30/1992CA1304376C Imidazolidinone compound and processes for preparation thereof
06/29/1992WO1992012140A1 Peptides ketoamides, ketoacids, and ketoesters
06/29/1992WO1992011850A2 Use of calpain inhibitors in the inhibition and treatment of neurodegeneration
06/29/1992CA2098702A1 Peptide ketoamides, ketoacids, and ketoesters
06/29/1992CA2098609A1 Use of calpain inhibitors in the inhibition and treatment of neurodegeneration
06/28/1992CA2057973A1 Method for alleviating anxiety using benzobicyclic carboxamides
06/25/1992WO1992011011A1 Use of certain glutarimide derivatives in the treatment of depression and mania
06/25/1992WO1992010477A1 Medicaments
06/25/1992WO1992010192A1 Indan derivatives
06/25/1992WO1992010186A1 Use of angiotensn ii receptor antagonists for the preparation of a medicament for improving cognitive function
06/25/1992WO1992010178A1 Antipruritic drug and antipruritic composition
06/25/1992WO1992010097A1 Angiotensin ii receptor blocking compositions
06/25/1992WO1992009586A1 Active oxygen inhibitor
06/25/1992WO1992008731A3 T-cadherin adhesion molecule
06/25/1992WO1992007564A3 Method of treating demyelinating disease
06/25/1992DE4041482A1 Neue pharmazeutische verwendung carbocyclisch und heterocyclisch annelierter dihydropyridine New pharmaceutical use carbocyclic and heterocyclic fused-dihydropyridines
06/25/1992DE4041465A1 10-cyanmethylen-4-(piperazin-1-yl)-pyrrolo (4,3-e)benzoazepinen zur bekaempfung der migraene 10-cyanomethylene-4- (piperazin-1-yl) pyrrolo (4,3-e) benzoazepinen aimed at fighting the migraene
06/25/1992CA2097607A1 Use of certain glutarimide derivatives in the treatment of depression and mania
06/24/1992EP0491664A1 Serotonin antagonists
06/24/1992EP0491586A1 Use in anaesthesia and pharmaceutical compositions of (S)-isoflurane and (S)-desflurane
06/24/1992EP0491549A1 Novel 15-nitro-2beta, 3beta-dihydro- and 15-nitro-2beta,3beta,6,7-tetrahydrotabersonine derivatives, pharmaceutical compositions containing them and process for preparing same
06/24/1992EP0491243A1 Alkylaminoalkylamino and -ether compounds as well as processes and intermediates for their preparation, and medicaments containing these compounds
06/24/1992EP0490962A1 Antipsychotic 1-cycloalkylpiperidines
06/24/1992EP0490901A1 Novel spirofurane derivatives
06/24/1992CN1062143A Condensed heterocyclic compouds, their production and use
06/23/1992WO1992011014A1 10-cyanomethylene-4-piperazine-1-yl)-pyrrolo[4,3e]benzoazepines for relieving migraine
06/23/1992US5124346 Synergistic combinations in the treatment of anxiety
06/23/1992US5124336 Azabenzimidazole derivatives which are thromboxane receptor antagonists
06/23/1992US5124335 Substituted pyrollo-fused 6 membered heterocycles as angiotensin ii antagonists
06/23/1992US5124319 Administering for treatment of neuropathological disorders induced by overstimulation of excitatory amino acid receptors
06/23/1992CA2098815A1 10-cyanomethylene-4-(1-piperazinyl)pyrrolo-[4,3-e] benzazepines for controlling migraine
06/23/1992CA1304082C Benzoxazine compounds and pharmaceutical use thereof
06/22/1992WO1992011262A1 1-(4-acylaminophenyl)-7,8-methylenedioxy-5h-2,3-benzo-diazepine derivatives and acid addition salts thereof, pharmaceutical compositions containing them and process for preparing same
06/22/1992WO1992011012A1 Use of quisqualate-receptor antagonists for treating parkinson's disease
06/22/1992CA2098922A1 Neuronal cholinergic differentiation factor
06/22/1992CA2098291A1 1-(4-acylaminophenyl)-7,8-methylenedioxy-5h-2,3-benzo- diazepine derivatives and acid addition salts thereof, pharmaceutical compositions containing them and process for preparingsame
06/22/1992CA2076524A1 New use of quisqualate receptor antagonists
06/22/1992CA2058228A1 Use of heptastigmine in the therapy of cerebral ictus
06/22/1992CA2058148A1 Process for the preparation of enantiomerically pure thienopyran derivative
06/20/1992WO1992011018A1 Improved humanized immunoglobulins
06/20/1992CA2057990A1 Alkylaminoalkylamine and ether compounds, processes and intermediates for their preparation, and medicaments containing them
06/19/1992CA2057829A1 15-nitro-2beta,3beta-dihydro- and 15-nitro-2beta,3beta,6,7-tetrahydro tabersonine derivatives, pharmaceutical compositions containing them andprocess for preparing same
06/19/1992CA2057391A1 Serotonin antagonists
06/17/1992EP0490772A1 1,4-Disubstituted piperazines, their process of preparation and pharmaceutical compositions containing them
06/17/1992EP0490765A2 1-Arylsulfonyl-2-pyrrolidone-derivatives, process for their preparation, new in termediates, use for medicaments and drugs containing them
06/17/1992EP0490689A1 3-[2-(dimethylamino)ethyl]-N-methyl-1H-indole-5-methanesulphonamide sulphate (2:1)
06/17/1992EP0490590A1 New benzodiazepine analogs
06/17/1992EP0490379A2 Diamino acid derivatives and pharmaceutical compositions
06/17/1992EP0490263A1 Alpha-oxoacetamide derivatives
06/17/1992CN1061971A Mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace
06/17/1992CN1061963A 4-substituted piperidine derivatives for use in therapy
06/16/1992US5122596 Polypeptides useful as blockers of calcium channels
06/16/1992US5122543 Syrup of carbamazepine in protective polymeric colloid
06/16/1992US5122528 Analgesic use of benzobicyclic carboxamides
06/16/1992US5122525 Pyrido(1,2-A) pyrazines
06/16/1992US5122461 Preparation of pyrocatecholic compounds
06/16/1992CA1303509C Pharmaceutical compositions containing levodopa methyl ester, preparation and therapeutic applications thereof
06/16/1992CA1303502C Sustained release pharmaceutical compositions in oral dosage form
06/14/1992CA2057601A1 Pharmaceutical use of diamino acid derivatives
06/11/1992WO1992009600A1 Benzofuran and benzthiophene derivatives
06/11/1992WO1992007832A3 Substituted piperazines as central nervous system agents
06/10/1992EP0489690A1 Substituted N-Benzoyl-N'-(2-phenylethyl)-piperazines
06/10/1992EP0489640A1 Use of phenylethanolaminotetralines for preparing antidepressant and anti-stress medicines
06/10/1992EP0489616A1 Use in anaesthesia and pharmaceutical compositions of (R)-isoflurane and (R)-desflurane
06/10/1992EP0489458A1 Hydroxyquinolone derivatives
06/10/1992EP0489379A1 5-amino-5,6,7,8-tetrahydroquinolines and related compounds, a process for their preparation and their use as medicaments
06/10/1992EP0489300A2 Tetralones with pharmacological activity
06/10/1992EP0489144A1 Freeze-dried hybrid mild pumpkin and drugs containing same
06/10/1992EP0489102A1 Pharmaceutical compositions containing aromatic polymers and therapeutic methods using the same
06/10/1992EP0489045A1 Onset-hastened/enhanced antipyretic response
06/09/1992US5120851 Preparation process for making water-soluble lysine salts of (+)2-(4-fluorophenyl)-alpha-methyl-5-benzoxazole acetic acid
06/09/1992US5120760 Administering gamma-linolenic acid and stearidonic acid
06/09/1992US5120759 Tetrahydronaphthalene derivatives for improving short-term memory
06/09/1992US5120736 Treatment of functional dysuria associated with hyperactivity of adrenergic smypathetic nervous system
06/09/1992US5120723 Alleviate stress, anxiety, seizures
06/09/1992US5120713 Treatment of obesity with an alpha-2-adrenergic agonist and a growth hormone releasing peptide
06/09/1992CA1303044C Benzhydryloxyethylpiperidine derivatives process for their preparation and pharmaceutical compositions in which they are present
06/09/1992CA1303025C 17-.beta. A-OH 19-NORSTEROIDS SUBSTITUTED IN 17A, PROCESS FOR THEIR PREPARATION, THEIR USE AS MEDICINES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
06/09/1992CA1302888C Therapeutic agent for the treatment of disorders associated with cerebral ischemia
06/09/1992CA1302878C Agent for the regulation of the appetite or a sleeping agent
06/08/1992WO1992010474A1 3-[2-chloro-4-(trifluoromethyl)phenoxy]-1-azetidine carboxamides having anticonvulsant activity
06/08/1992WO1992010099A1 Excitatory amino acid antagonists
06/08/1992CA2097910A1 Excitatory amino acid antagonists
06/08/1992CA2097835A1 3-[2-chloro-4-(trifluoromethyl)phenoxy]- 1-azetidine carboxamides having anticonvulsant activity
06/08/1992CA2057181A1 Scrotonergic .alpha.-oxoacetamide
06/08/1992CA2056809A1 Benzodiazepine analogs
06/06/1992CA2056922A1 Tetralones with pharmacological activity
06/06/1992CA2056874A1 Substituted n-benzoyl-n'-(2-phenylethyl)-piperazines
06/06/1992CA2056808A1 Hydroxyquinolone derivatives
06/04/1992DE4038128A1 8-en-19, 11(beta)-ueberbrueckte steroide, deren herstellung und diese enthaltende pharmazeutische praeparate 8-ene-19, 11 (beta) -ueberbrueckte steroids, their production and pharmaceutical compositions containing them
06/04/1992CA2056201A1 Treatment of sleep disorders
06/03/1992EP0488959A2 New uses of competitive NMDA receptor antagonists